Synthesis, Cytotoxicity, and Pro-Apoptosis Activity of Etodolac Hydrazide Derivatives as Anticancer Agents

Synthesis of new pyrazole, triazole, and thiazolidine-pyrimido [4, 5-b] quinoline derivatives with potential antitumor activity

(2012) Ameen Ali Abu-Hashem et al.   ARCHIVES OF PHARMACAL RESEARCH

Synthesis and Antimycobacterial Activity of a Novel Series of Isonicotinylhydrazide Derivatives

(2009) Sandip Jaju et al.   ARCHIV DER PHARMAZIE

Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells

(2009) Liang-Wen Zheng et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety

(2009) Hend N. Hafez et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells

(2009) Wei-Yong Liu et al.   CARBOHYDRATE RESEARCH

Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

(2009) M. H. Kang et al.   CLINICAL CANCER RESEARCH

Synthesis and antitumor activity of some new xanthotoxin derivatives

(2009) Omaima M. Abdel Hafez et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

(2009) R. E. Harris   INFLAMMOPHARMACOLOGY

Etodolac, a Selective Cyclooxygenase-2 Inhibitor, Induces Upregulation of E-Cadherin and Has Antitumor Effect on Human Bladder Cancer Cells In Vitro and In Vivo

(2008) Asako Okamoto et al.   UROLOGY

4-Thiazolidinone – A biologically active scaffold

(2007) Amit Verma et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY